Editor-in-Chief Lisa Henderson spoke with DrugDev Founder and President, Site Startup Liss Easy about the potential impact of our new Site Activation technology on reducing trial startup activities by at least 20%
Important Cookie Information – This message will only appear once.
DrugDev websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy.
